Platinum Industries Palghar Facility Becomes Fully Operational; Fulfills Key IPO Objective
Platinum Industries Ltd has successfully transitioned its Palghar manufacturing unit to full operational status after commencing commercial production of its remaining facilities. This development follows a partial start in August 2025 and fulfills a strategic commitment made during the company's initial public offering.
Atul Ltd Launches Innovative Mylonis, Salix Gold, and Tikadis Crop Protection Products
Atul Ltd has expanded its retail agricultural portfolio by launching three proprietary crop protection solutions targeting rice and oilseed farmers. These innovations, comprising two patented formulations and a high-purity herbicide, aim to address critical gaps in disease and weed management across the Indian domestic market.
Vishnu Chemicals Resumes Full Production at Visakhapatnam Plant; TTM Revenue at ₹1,552 Cr
Vishnu Chemicals has announced the successful completion of maintenance activities at its Parwada facility in Visakhapatnam, Andhra Pradesh. The plant has returned to full operational capacity as of May 12, 2026, following a planned shutdown period that commenced in mid-April. This resumption ensures normalized supply for the specialty chemical manufacturer key product lines.
AVI Polymers Launches Ashwini Healthcare AI with 5,620 Users and ₹12 Cr ARR Target
AVI Polymers Ltd has officially introduced Ashwini Healthcare AI, a dedicated HealthTech SaaS platform that has already secured a waitlist of over 5,620 organic users. The company expects to convert this early interest into a recurring revenue stream with a baseline Year-1 Annual Recurring Revenue projected between ₹6.00 Lakhs and ₹9.00 Lakhs.
Privi Speciality Chemicals Receives NSE No Objection for Amalgamation Scheme
Privi Speciality Chemicals has cleared a major regulatory milestone by obtaining a 'no objection' observation letter from the National Stock Exchange of India for its proposed merger. The scheme involves integrating Privi Fine Sciences and Privi Biotechnologies into the parent entity to streamline operations and enhance group synergies.